D’Orazio to lead industrial imaging arm of SHINE Tom [...]
JANESVILLE and FITCHBURG, Wis., April 20, 2021 – SHINE Medical Technologies LLC and Phoenix LLC today announced that the companies have completed a merger under which Phoenix has become a wholly owned subsidiary of SHINE.
SHINE and Phoenix tested the first production-ready accelerator in SHINE’s Janesville facility over the course of 5.5 days to determine percentage uptime and total neutron output. The average system neutron yield was measured to be 10% percent beyond the required output, with greater than 99 percent uptime.
Phoenix has delivered the first production accelerator to SHINE’s Building One, the first building on the SHINE medical isotope production campus in Janesville, WI.